Wednesday, February 10, 2010, 10:38AM AEST - The Australian Stockmarket closes in 5 hours and 27 minutes.
To create a watchlist or portfolio of shares, Register

Nektar Therapeutics (NKTR)

 8:00AM AEST: 11.71 USD  Up 0.31 (2.72%)  
 MORE ON NKTR 
Quotes
Charts
Technical Analysis
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
HeadlinesGet Headlines for:
Tue, Feb 9, 2010
•Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Tue 9:34AM)
Fri, Feb 5, 2010
•NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
EDGAR Online (Fri, Feb 5)
Wed, Feb 3, 2010
•NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia
EDGAR Online (Wed, Feb 3)
•Nektar appoints Greer to board
AP (Wed, Feb 3)
•Nektar adds to board of directors
at bizjournals.com (Wed, Feb 3)
•Nektar Therapeutics Appoints R. Scott Greer to Board of Directors
PR Newswire (Wed, Feb 3)
Tue, Feb 2, 2010
•Symantec adds former Intuit CEO to board
at bizjournals.com (Tue, Feb 2)
Wed, Jan 27, 2010
•3 Stocks Ready to Roar
at Motley Fool (Wed, Jan 27)
•Wall Street's Buy List
at Motley Fool (Wed, Jan 27)
Tue, Jan 26, 2010
•Earnings Surprises For Diagnostics Companies Creates Good Stock Price Entry Point For New Investors According To Industry Expert
Wall Street Transcript (Tue, Jan 26)
Thu, Jan 14, 2010
•Tech Showing Signs of Life
Indie Research (Thu, Jan 14)
•Preliminary Data from Nektar
Zacks.com (Thu, Jan 14)
Wed, Jan 13, 2010
•UPDATE - Nektar posts prelim data from cancer trial
at Reuters (Wed, Jan 13)
•NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Jan 13)
•Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer
PR Newswire (Wed, Jan 13)
Tue, Jan 12, 2010
•Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors
PR Newswire (Tue, Jan 12)
Thu, Jan 7, 2010
•Nektar names first chief science officer
at bizjournals.com (Thu, Jan 7)
•Nektar Therapeutics Names Stephen K. Doberstein, Ph.D. Senior Vice President and Chief Scientific Officer
PR Newswire (Thu, Jan 7)
•Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
PR Newswire (Thu, Jan 7)
Wed, Dec 23, 2009
•Tomorrow's Monster Stock?
at Motley Fool (Wed, Dec 23)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
•Latest News•7 Indices